Sara Gallini

Sara received her B.S. and M.S. degrees in Biotechnology and Medical Biotechnology from the University of Bologna and her PhD in Molecular Medicine from the University of Milan. She performed her doctoral work at the European Institute of Oncology (IEO) in Milan in the lab of Dr. Marina Mapelli, where she discovered the novel mitotic spindle orientation functions of Aurora-A kinase and of the actin-binding protein Afadin. Sara joined the lab of Dr. Valentina Greco at Yale University as a postdoctoral fellow where she identified the cellular and molecular mechanisms that suppress skin cancer initiation during injury-repair. In October of 2024, she will open her independent lab in the School of Life Sciences (SV) and Swiss Institute for Experimental Cancer Research (ISREC) at EPFL, Switzerland.